Clinical Trial Update: Neo-adjuvant SABR for IVC Tumor Thrombus in Newly Diagnosed RCC [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial evaluating neoadjuvant stereotactic ablative radiotherapy for renal cell carcinoma with inferior vena cava tumor thrombus. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Renal Cell Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING